Consideration 01
Adults who meet individual medical criteria
A provider reviews whether this consideration fits your complete health picture and available care options.
Prescription appetite support · California
Phendimetrazine Weight Loss
Support that is selected carefully—and monitored personally.
Care starts with the whole picture.
Short-term appetite support requires an individual decision and a defined monitoring plan.
Phendimetrazine is a prescription appetite suppressant that may be appropriate for select patients as part of a medically supervised plan.
MEDY evaluates health history, current medications, blood pressure, goals, and potential risks before considering treatment. Follow-up focuses on response, tolerance, and the broader habits that support long-term progress.
MEDY’s clinical care is led by Christel Backert, NP-C. Recommendations are based on the individual evaluation, and treatment education includes reasonable expectations, alternatives, and the follow-up needed for the option being considered.
Phendimetrazine evaluation is currently offered in person at the Lathrop and Modesto clinics.
Who may want to begin the conversation.
Interest starts the discussion. Individual health information determines the recommendation.
Consideration 02
Patients seeking structured appetite support
A provider reviews whether this consideration fits your complete health picture and available care options.
Consideration 03
People able to participate in consistent monitoring
A provider reviews whether this consideration fits your complete health picture and available care options.
Consideration 04
Patients who want clear expectations and follow-up
Discuss the option’s intended role, limitations, monitoring, and how it may fit within a broader care plan.
What to expect from the evaluation.
A defined conversation helps turn general interest into an informed next step.
Individual medical assessment
Share the information your provider needs to understand your health, goals, and current care.
Review of risks and alternatives
Discuss the option’s intended role, limitations, possible risks, and reasonable alternatives.
Clear treatment expectations
Receive clear guidance when treatment is recommended, including what to watch for and what comes next.
A planned follow-up schedule
Use follow-up to review your experience and decide whether the plan should continue, change, or conclude.
A controlled medication requires careful screening.
Questions about cardiovascular health, other medications, duration, and monitoring belong in the first conversation.
Phendimetrazine is a controlled prescription medication and is not appropriate for every patient. The prescribing provider reviews blood pressure, cardiovascular history, current medications, possible contraindications, and other individual risks before deciding whether it should be considered. Website information cannot replace prescription instructions or individual medical advice.
Do not start, stop, share, or change a prescription or injection plan based on website information. Follow the directions provided by the treating clinician and contact the MEDY team with treatment or side-effect questions.
Questions about phendimetrazine weight loss?
Is this medication appropriate for long-term use?
Treatment duration is determined individually by the prescribing provider.
Will I need monitoring?
Yes. Regular follow-up is an important part of prescription weight management.
Are other options available?
Yes. MEDY considers the full range of appropriate options rather than assuming one medication fits everyone.
Will I automatically receive this treatment?
No. A provider reviews your individual information, treatment goals, possible risks, and reasonable alternatives before making a recommendation.
Where is this care available?
Phendimetrazine evaluation is currently offered in person at the Lathrop and Modesto clinics.